BULL CERTIFICATE - ORION B | Market Closed - Nasdaq Helsinki 08:49:22 06/06/2024 BST | ||
| 6.86 EUR | +7.52% |
|
| 3 months | +26.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 6.86 | +7.52% |
Delayed Quote Nasdaq Helsinki
Last update June 06, 2024 at 08:49 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Nordea |
| BULL ORION X3 N | |
| ISIN | SE0016279194 |
| Date issued | 08/07/2021 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.2 € |
|---|---|
| Lowest since issue | 4.06 € |
| Spread | 0.05 € |
| Spread % | 0.74% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
38.94
EUR
Average target price
39
EUR
Spread / Average Target
+0.15%
- Stock Market
- Certificates
- BULL ORION X3 N Certificat
